Viewing StudyNCT01284192



Ignite Creation Date: 2024-05-05 @ 11:15 PM
Last Modification Date: 2024-10-26 @ 10:30 AM
Study NCT ID: NCT01284192
Status: COMPLETED
Last Update Posted: 2016-06-28
First Post: 2011-01-25

Brief Title: Study of an Investigational Drug ASP3026 in Patients With Advanced Malignancies Solid Tumors and B-Cell Lymphoma
Sponsor: Astellas Pharma Inc
Organization: Astellas Pharma Inc

Conditions & Keywords Data

Conditions:
Name
B-Cell Lymphoma
Advanced Malignancies
Positive for Anaplastic Lymphoma Kinase
Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS
Solid Tumor
Keywords:
Name View
Solid Tumor View
B-cell Lymphoma View
Advanced Malignancies View
Anaplastic Lymphoma Kinase ALK View
ASP3026 View